Propacetamol

PreclinicalSmall molecule

YYonsei University

Propacetamol is one of 60 small molecule programs targeting Hernia. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Atrial FibrillationActive, not recruiting

Cesarean SectionActive, not recruiting

Atrial FibrillationPreclinical

Active, not recruiting

Cesarean SectionPreclinical

Active, not recruiting

Competition

Competitive Landscape

376 competitors in Atrial Fibrillation

#DrugCompanyPhaseTrials

Calquence

AstraZeneca

Preclinical

1 2

Calan

VVal Adams

Preclinical

4 3

Brukinsa

BBeOne Medicines

Preclinical

1 4

Imbruvica

PPharmacyclics LLC.

Preclinical

1 5

Xylocaine

MMEDRx USA, Inc.

Preclinical

1 6

Ondexxya

UUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology

Preclinical

1 7

Romazicon

CConrado Roberto Hoffmann Filho

Preclinical

1 8

Low-Molecular-Weight Heparin

Daiichi Sankyo

Preclinical

1 9

Liquamar

OOrganon and Co

Preclinical

4 10

Magnesium SO4

HHospital de Base

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Postoperative Quality of Recovery1 trial

A Comparison of Nefopam-propacetamol Combination and Propacetamol for Postoperative Quality of Recovery After Laparoscopic Nephrectomy

Completed·YYonsei University·N/A·NCT01833728·16 enrolled

Cesarean Section1 trial

Propacetamol to Reduce Post Cesarean Section Uterine Contraction Pain

Completed·MMackay Memorial Hospital·N/A·NCT03878082·100 enrolled

Hernia1 trial

Comparison of the Effect of Propacetamol, Ibuprofen or Their Combination on Postoperative Pain and Quality of Recovery After Laparoscopic Hernia Repair in Children

Completed·YYonsei University·N/A·NCT03352362·159 enrolled

Atrial Fibrillation1 trial

The Effect of Additional Propacetamol Infusion on Post Procedural Outcome and Opioid Consumption During Catheter Ablation of Atrial Fibrillation.

Completed·YYonsei University·N/A·NCT02515188·98 enrolled

High Risk1 trial

The Opioid-sparing Effect and Reduced PONV Using Propacetamol in PCA Among Patients With High Risk of PONV

Completed·YYonsei University·N/A·NCT02116257·108 enrolled

1 more indication

Post Operative Pain1 trial

Combination Effect of Nefopam With Propacetamol for Postoperative Pain After Thyroidectomy

Completed·YYonsei University·N/A·NCT02577068·84 enrolled

Sources

References

[1]
ClinicalTrials.gov — 6 trial records for Propacetamol. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Propacetamol compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Propacetamol. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Yonsei University company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: YYonsei University

Propacetamol

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Postoperative Quality of Recovery1 trial

Cesarean Section1 trial

Hernia1 trial

Atrial Fibrillation1 trial

High Risk1 trial

Post Operative Pain1 trial

References

Drug Info

Quick Facts

Related News